Symmans W Fraser
Department of Pathology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Semin Oncol. 2007 Apr;34(2 Suppl 3):S4-9. doi: 10.1053/j.seminoncol.2007.03.016.
Emerging molecular tests for breast cancer indicate how future progress in diagnostic pathology might guide patient care. However, the challenge will be to bring the best results from this exciting research into clinical use as accurate and reliable standardized tests that integrate into the diagnostic work-up.
新兴的乳腺癌分子检测表明了诊断病理学未来的进展如何指导患者护理。然而，挑战在于将这项令人兴奋的研究成果转化为临床应用，成为准确可靠的标准化检测方法，并融入诊断检查流程中。
